Fenu E - Search Results

1

Cost-effectiveness of maribavir versus conventional antiviral therapies for post-transplant refractory cytomegalovirus infection with or without genotypic resistance: A US perspective.

Schultz BG, Kotton CN, Jutlla G, Ressa R, de Lacey T, Chowdhury E, Bo T, Fenu E, Gelone DK, Poirrier JE, Amorosi SL. Schultz BG, et al. Among authors: fenu e. J Med Virol. 2024 Apr;96(4):e29609. doi: 10.1002/jmv.29609. J Med Virol. 2024. PMID: 38647051

2

Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France.

Oppe M, Muresan B, Chan K, Radu X, Schultz BG, Turpin RS, Nucit A, Fenu E. Oppe M, et al. Among authors: fenu e. Expert Rev Pharmacoecon Outcomes Res. 2023 Feb;23(2):205-213. doi: 10.1080/14737167.2023.2160322. Epub 2023 Jan 5. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 36541707

3

Immunohistochemistry-based detection of TP53 mutations in acute myeloid leukemia: a promising high sensitivity diagnostic approach.

Matthews A, Fenu E, Skuli SJ, Harris JC, Bagg A, Lai C. Matthews A, et al. Among authors: fenu e. Leuk Lymphoma. 2024 Jul;65(7):1012-1015. doi: 10.1080/10428194.2024.2332505. Epub 2024 Mar 27. Leuk Lymphoma. 2024. PMID: 38535517 No abstract available.

4

Primary cutaneous T-follicular helper lymphoma.

Fenu EM, Milman T, Penne R, Navarro FE, Yang G, Bagg A. Fenu EM, et al. EJHaem. 2023 Jul 31;4(4):1176-1178. doi: 10.1002/jha2.737. eCollection 2023 Nov. EJHaem. 2023. PMID: 38024630 Free PMC article. No abstract available.

5

VEXAS'd by lymphadenopathy: an unusual case of extramedullary hematopoiesis.

Fenu EM, Bagg A. Fenu EM, et al. Blood. 2023 Jun 1;141(22):2784. doi: 10.1182/blood.2023020012. Blood. 2023. PMID: 37261849 Free article. No abstract available.

6

Transdifferentiation of B-lymphoblastic leukemia to histiocytic sarcoma after immunotherapy.

Fenu EM, Margolskee E, Pillai V. Fenu EM, et al. Am J Hematol. 2023 Aug;98(8):E216-E218. doi: 10.1002/ajh.26983. Epub 2023 Jun 1. Am J Hematol. 2023. PMID: 37259821 Free article. No abstract available.

7

TP53 in AML and MDS: The new (old) kid on the block.

Marks JA, Wang X, Fenu EM, Bagg A, Lai C. Marks JA, et al. Among authors: fenu em. Blood Rev. 2023 Jul;60:101055. doi: 10.1016/j.blre.2023.101055. Epub 2023 Feb 14. Blood Rev. 2023. PMID: 36841672 Review.

8

Storage Artifact Masquerading as Yeast: Presenting a Diagnostic Pitfall.

Fenu EM, Naal T, Palavecino E. Fenu EM, et al. Case Rep Pathol. 2022 Oct 8;2022:3326214. doi: 10.1155/2022/3326214. eCollection 2022. Case Rep Pathol. 2022. PMID: 36254229 Free PMC article.

9

Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada.

Fenu E, Lukyanov V, Acs A, Radu X, Stypa S, Fischer A, Marshall JK, Oppe M. Fenu E, et al. Pharmacoecon Open. 2022 Jul;6(4):519-537. doi: 10.1007/s41669-022-00331-9. Epub 2022 Apr 26. Pharmacoecon Open. 2022. PMID: 35474178 Free PMC article.

10

Cardiac Involvement by Human Herpesvirus 8-Positive Diffuse Large B-Cell Lymphoma: An Unusual Presentation in a Patient with Human Immunodeficiency Virus.

Fenu EM, Beaty MW, O'Neill TE, O'Neill SS. Fenu EM, et al. Case Rep Pathol. 2022 Jan 17;2022:1298121. doi: 10.1155/2022/1298121. eCollection 2022. Case Rep Pathol. 2022. PMID: 35083089 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters